BERNARD FANGET,GÉRALDINE GROUARD-VOGEL,OLIVIER DHELLIN,PIERRE VANDEPAPELIÉRE
申请号：
BR112013014302
公开号：
BR112013014302A2
申请日:
2011.12.08
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
An immunogenic product includes TNFalpha coupled with KLH, wherein the TNFalpha is strongly inactivated, which means that the product shows less than 30% of cytolytic activity and/or an inactivation factor of more than 15000, in the conditions of TEST A. An emulsion and a vaccine including the product and methods for preparing the immunogenic product are also described.
